Journal article
Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study
BMC pulmonary medicine, Vol.16(1), pp.169-169
12/01/2016
DOI: 10.1186/s12890-016-0331-0
PMCID: PMC5131397
PMID: 27903260
Abstract
Hypoxemia is a major complication of COPD and is a strong predictor of mortality. We previously identified independent risk factors for the presence of resting hypoxemia in the COPDGene cohort. However, little is known about characteristics that predict onset of resting hypoxemia in patients who are normoxic at baseline. We hypothesized that a combination of clinical, physiologic, and radiographic characteristics would predict development of resting hypoxemia after 5-years of follow-up in participants with moderate to severe COPD METHODS: We analyzed 678 participants with moderate-to-severe COPD recruited into the COPDGene cohort who completed baseline and 5-year follow-up visits and who were normoxic by pulse oximetry at baseline. Development of resting hypoxemia was defined as an oxygen saturation ≤88% on ambient air at rest during follow-up. Demographic and clinical characteristics, lung function, and radiographic indices were analyzed with logistic regression models to identify predictors of the development of hypoxemia.
Forty-six participants (7%) developed resting hypoxemia at follow-up. Enrollment at Denver (OR 8.30, 95%CI 3.05-22.6), lower baseline oxygen saturation (OR 0.70, 95%CI 0.58-0.85), self-reported heart failure (OR 6.92, 95%CI 1.56-30.6), pulmonary artery (PA) enlargement on computed tomography (OR 2.81, 95%CI 1.17-6.74), and prior severe COPD exacerbation (OR 3.31, 95%CI 1.38-7.90) were independently associated with development of resting hypoxemia. Participants who developed hypoxemia had greater decline in 6-min walk distance and greater 5-year decline in quality of life compared to those who remained normoxic at follow-up.
Development of clinically significant hypoxemia over a 5-year span is associated with comorbid heart failure, PA enlargement and severe COPD exacerbation. Further studies are needed to determine if treatments targeting these factors can prevent new onset hypoxemia.
COPDGene is registered at ClinicalTrials.gov: NCT00608764 (Registration Date: January 28, 2008).
Details
- Title: Subtitle
- Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study
- Creators
- J Michael Wells - , 1900 University Blvd, THT 422, Birmingham, AL, 35294, USA. jmwells@uabmc.eduRaul San Jose Estepar - Department of Radiology, Brigham and Women's Hospital, Boston, MA, USAMerry-Lynn N McDonald - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USASurya P Bhatt - Lung Health Center University of Alabama Birmingham, Birmingham, AL, USAAlejandro A Diaz - Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, USAWilliam C Bailey - Lung Health Center University of Alabama Birmingham, Birmingham, AL, USAFrancine L Jacobson - Department of Radiology, Brigham and Women's Hospital, Boston, MA, USAMark T Dransfield - Birmingham VA Medical Center, Birmingham, AL, USAGeorge R Washko - Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, MA, USABarry J Make - Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USARichard Casaburi - Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA, USAEdwin J R van Beek - Department of Radiology, University of Edinburgh, Edinburgh, Scotland, UKEric A Hoffman - Department of Radiology, University of Iowa, Iowa City, IA, USAFrank C Sciurba - Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USAJames D Crapo - Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO, USAEdwin K Silverman - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USACraig P Hersh - Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- Resource Type
- Journal article
- Publication Details
- BMC pulmonary medicine, Vol.16(1), pp.169-169
- DOI
- 10.1186/s12890-016-0331-0
- PMID
- 27903260
- PMCID
- PMC5131397
- NLM abbreviation
- BMC Pulm Med
- ISSN
- 1471-2466
- eISSN
- 1471-2466
- Publisher
- England
- Grant note
- K01 HL118714 / NHLBI NIH HHS R01 HL116931 / NHLBI NIH HHS K08 HL123940 / NHLBI NIH HHS R01 HL125583 / NHLBI NIH HHS R01 HL089856 / NHLBI NIH HHS S10 OD018526 / NIH HHS UL1 TR001417 / NCATS NIH HHS KL2 TR001419 / NCATS NIH HHS R01 HL089897 / NHLBI NIH HHS R01 HL094635 / NHLBI NIH HHS R01 HL116473 / NHLBI NIH HHS
- Language
- English
- Date published
- 12/01/2016
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Internal Medicine
- Record Identifier
- 9984051710502771
Metrics
21 Record Views